Semin Reprod Med 2010; 28(2): 103-109
DOI: 10.1055/s-0030-1248134
© Thieme Medical Publishers

Transcervical Sterilization

Paula M. Castaño1 , Lola Adekunle1
  • 1Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York
Further Information

Publication History

Publication Date:
29 March 2010 (online)

ABSTRACT

Sterilization is frequently chosen as a method of permanent contraception. Traditional approaches involve surgery under anesthesia in an operating room and are associated with a recovery period and scars. Transcervical sterilization is an incision-free, minimally invasive approach to sterilization. When compared with laparoscopic surgery, transcervical hysteroscopic sterilization does not need to be performed in an operating room, requires less anesthesia, has a shorter recovery period, and is more cost effective. The Essure Permanent Birth Control System (Conceptus, Inc., Mountain View, CA) and Adiana Permanent Contraception System (Hologic, Inc., Bedford, MA) are two available hysteroscopic sterilization techniques. They cause fibrosis and tubal occlusion over a 3-month period so women must use an alternative form of contraception during the first 3 months. A 3-month hysterosalpingogram confirms successful placement and tubal occlusion. Transcervical sterilization is similarly effective to other sterilization methods and is satisfactory to women.

REFERENCES

  • 1 Dowbiggin I. The Sterilization Movement and Global Fertility in the Twentieth Century. New York, NY; Oxford University Press 2008: 21-23
  • 2 Chandra A, Martinez G M, Mosher W D, Abma J C, Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth.  Vital Health Stat 23. 2005;  (25) 1-160
  • 3 Westhoff C, Davis A. Tubal sterilization: focus on the U.S. experience.  Fertil Steril. 2000;  73(5) 913-922
  • 4 MacKay A P, Kieke Jr B A, Koonin L M, Beattie K. Tubal sterilization in the United States, 1994–1996.  Fam Plann Perspect. 2001;  33(4) 161-165
  • 5 Barone M A, Hutchinson P L, Johnson C H, Hsia J, Wheeler J. Vasectomy in the United States, 2002.  J Urol. 2006;  176(1) 232-236, discussion 236
  • 6 Jamieson D J, Hillis S D, Duerr A, Marchbanks P A, Costello C, Peterson H B. Complications of interval laparoscopic tubal sterilization: findings from the United States Collaborative Review of Sterilization.  Obstet Gynecol. 2000;  96(6) 997-1002
  • 7 Peterson H B, Xia Z, Hughes J M, Wilcox L S, Tylor L R, Trussell J. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization.  Am J Obstet Gynecol. 1996;  174(4) 1161-1168, discussion 1168–1170
  • 8 Hieu D T, Tan T T, Tan D N, Nguyet P T, Than P, Vinh D Q. 31,781 cases of non-surgical female sterilisation with quinacrine pellets in Vietnam.  Lancet. 1993;  342(8865) 213-217
  • 9 Agoestina T, Hoesni R HM, Purwara B H et al.. Randomized trial of one versus two transcervical insertions of quinacrine pellets for sterilization.  Fertil Steril. 2002;  77(5) 1065-1068
  • 10 Sokal D C, Hieu T, Loan N D et al.. Contraceptive effectiveness of two insertions of quinacrine: results from 10-year follow-up in Vietnam.  Contraception. 2008;  78(1) 61-65
  • 11 Lippes J. Quinacrine sterilization: the imperative need for American clinical trials.  Fertil Steril. 2002;  77(6) 1106-1109
  • 12 Benagiano G. An introduction to the supplement.  Int J Gynaecol Obstet. 2003;  83 S1-S2
  • 13 Clinicaltrials.gov .Available at: http://www.clinicaltrials.gov/ Accessed October 17, 2009
  • 14 Kerin J F, Cooper J M, Price T et al.. Hysteroscopic sterilization using a micro-insert device: results of a multicentre Phase II study.  Hum Reprod. 2003;  18(6) 1223-1230
  • 15 Cooper J M, Carignan C S, Cher D, Kerin J F. Selective Tubal Occlusion Procedure 2000 Investigators Group . Microinsert nonincisional hysteroscopic sterilization.  Obstet Gynecol. 2003;  102(1) 59-67
  • 16 Sinha D, Kalathy V, Gupta J K, Clark T J. The feasibility, success and patient satisfaction associated with outpatient hysteroscopic sterilisation.  BJOG. 2007;  114(6) 676-683
  • 17 Shavell V I, Abdallah M E, Diamond M P, Berman J M. Placement of a permanent birth control device at a university medical center.  J Reprod Med. 2009;  54(4) 218-222
  • 18 Ubeda A, Labastida R, Dexeus S. Essure: a new device for hysteroscopic tubal sterilization in an outpatient setting.  Fertil Steril. 2004;  82(1) 196-199
  • 19 Levie M D, Chudnoff S G. Prospective analysis of office-based hysteroscopic sterilization.  J Minim Invasive Gynecol. 2006;  13(2) 98-101
  • 20 Arjona J E, Miño M, Cordón J, Povedano B, Pelegrin B, Castelo-Branco C. Satisfaction and tolerance with office hysteroscopic tubal sterilization.  Fertil Steril. 2008;  90 1182-1186
  • 21 Levy B, Levie M D, Childers M E. A summary of reported pregnancies after hysteroscopic sterilization.  J Minim Invasive Gynecol. 2007;  14(3) 271-274
  • 22 Veerseema S, Vleugels M P, Moolenaar L M, Janssen C A, Brölmann H A. Unintended pregnancies after Essure sterilization in the Netherlands.  Fertil Steril. 2008;  , November 20 (Epub ahead of print)
  • 23 Hastings-Tolsma M, Nodine P, Teal S B, Embry J. Pregnancy outcome after transcervical hysteroscopic sterilization.  Obstet Gynecol. 2007;  110(2 Pt 2) 504-506
  • 24 Ory E M, Hines R S, Cleland W H, Rehberg J F. Pregnancy after microinsert sterilization with tubal occlusion confirmed by hysterosalpingogram.  Obstet Gynecol. 2008;  111(2 Pt 2) 508-510
  • 25 Moses A W, Burgis J T, Bacon J L, Risinger J. Pregnancy after Essure® placement: report of two cases.  Fertil Steril. 2008;  89(3) e9-e11(3)
  • 26 Ploteau S, Lopes P. Pregnancy after hysteroscopic tubal sterilization despite two hysterosalpingograms showing bilateral occlusion.  Eur J Obstet Gynecol Reprod Biol. 2009;  147(2) 238-239
  • 27 Duffy S, Marsh F, Rogerson L et al.. Female sterilisation: a cohort controlled comparative study of ESSURE versus laparoscopic sterilisation.  BJOG. 2005;  112(11) 1522-1528
  • 28 Baxter N, Hudson H, Rogerson L, Duffy S. Hysteroscopic sterilisation: a study of women's attitudes to a novel procedure.  BJOG. 2005;  112(3) 360-362
  • 29 Famuyide A O, Hopkins M R, El-Nashar S A et al.. Hysteroscopic sterilization in women with severe cardiac disease: experience at a tertiary center.  Mayo Clin Proc. 2008;  83(4) 431-438
  • 30 Levie M D, Chudnoff S G. Office hysteroscopic sterilization compared with laparoscopic sterilization: a critical cost analysis.  J Minim Invasive Gynecol. 2005;  12(4) 318-322
  • 31 Hopkins M R, Creedon D J, Wagie A E, Williams A R, Famuyide A O. Retrospective cost analysis comparing Essure hysteroscopic sterilization and laparoscopic bilateral tubal coagulation.  J Minim Invasive Gynecol. 2007;  14(1) 97-102
  • 32 Thiel J A, Carson G D. Cost-effectiveness analysis comparing the Essure tubal sterilization procedure and laparoscopic tubal sterilization.  J Obstet Gynaecol Can. 2008;  30(7) 581-585
  • 33 Franchini M, Cianferoni L, Lippi G et al.. Tubal sterilization by laparoscopy or hysteroscopy: which is the most cost-effective procedure?.  Fertil Steril. 2009;  91(4, suppl) 1499-1502
  • 34 Kraemer D F, Yen P Y, Nichols M. An economic comparison of female sterilization of hysteroscopic tubal occlusion with laparoscopic bilateral tubal ligation.  Contraception. 2009;  80(3) 254-260
  • 35 Shavell V I, Abdallah M E, Diamond M P, Kmak D C, Berman J M. Post-Essure hysterosalpingography compliance in a clinic population.  J Minim Invasive Gynecol. 2008;  15(4) 431-434
  • 36 Shavell V I, Abdallah M E, Shade Jr G H, Diamond M P, Berman J M. Trends in sterilization since the introduction of Essure hysteroscopic sterilization.  J Minim Invasive Gynecol. 2009;  16(1) 22-27
  • 37 Nichols M, Carter J F, Fylstra D L, Childers M. Essure System U.S. . A comparative study of hysteroscopic sterilization performed in-office versus a hospital operating room.  J Minim Invasive Gynecol. 2006;  13(5) 447-450
  • 38 Panel P, Grosdemouge I. Predictive factors of Essure implant placement failure: prospective, multicenter shtudy of 495 patients.  Fertil Steril. 2008; 
  • 39 Lett C D, Thiel J A. The effect of menstrual phase and hormonal contraception on successful bilateral placement of the Essure micro-insert tubal coil.  Gynecol Surg. 2009;  6 219-222
  • 40 Agostini A, Crochet P, Petrakian M, Estrade J P, Cravello L, Gamerre M. Hysteroscopic tubal sterilization (Essure) in women with an intrauterine device.  J Minim Invasive Gynecol. 2008;  15(3) 277-279
  • 41 Connor V F. Essure: a review six years later.  J Minim Invasive Gynecol. 2009;  16(3) 282-290
  • 42 Valle R F, Valdez J, Wright T C, Kenney M. Concomitant Essure tubal sterilization and Thermachoice endometrial ablation: feasibility and safety.  Fertil Steril. 2006;  86(1) 152-158
  • 43 Donnadieu A C, Deffieux X, Gervaise A, Faivre E, Frydman R, Fernandez H. Essure sterilization associated with endometrial ablation.  Int J Gynaecol Obstet. 2007;  97(2) 139-142
  • 44 Jansen N E, Vleugels M PH, Kluivers K B, Vierhout M E. Bilateral cornual abscess after endometrial ablation following Essure sterilization.  J Minim Invasive Gynecol. 2007;  14(4) 509-511
  • 45 Vancaillie T G, Anderson T L, Johns D A. A 12-month prospective evaluation of transcervical sterilization using implantable polymer matrices.  Obstet Gynecol. 2008;  112(6) 1270-1277
  • 46 FDA Summary of Safety and Effectiveness Data .Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf7/P070022b.pdf Accessed October 16, 2009
  • 47 Adiana® Permanent Contraception—Adiana and NovaSure® Web site. Available at: http://www.adiana.com/hcp/adiana_novasure/adiana-novasure-serial-use.html Accessed October 16, 2009

Paula M CastañoM.D. M.P.H. 

Assistant Clinical Professor, Department of Obstetrics and Gynecology, Columbia University Medical Center

622 W 168th St., PH 16-69, New York, NY 10032

Email: pc2137@columbia.edu

    >